Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Krishna Institute of Medical Sciences Ltd Share Price
Day's Range
Day's Range
Low
₹787.00
High
₹806.00
Price Summary
| Previous Close | ₹796.20 |
|---|---|
| Day's Range | ₹787.00 - ₹806.00 |
| Open | ₹806.00 |
| 52 Week Range | ₹575.80 - ₹811.00 |
| Volume | 4,82,004 |
| Market Cap | ₹0.03 |
| Previous Close | ₹793.00 |
|---|---|
| Day's Range | ₹787.15 - ₹809.90 |
| Open | ₹809.90 |
| 52 Week Range | ₹575.55 - ₹810.20 |
| Volume | 31,091 |
| Market Cap | ₹0.03 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 3,837.72 |
|---|---|
| Market Cap (₹ in Mn) | 0.03 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 132.71 |
| TTM EPS (₹) | 6.03 |
| P/E Ratio | 66.51 |
| Book Value(₹) | 14.25 |
| PAT Margin (%) | 13.67 |
| Face Value (₹) | 2.00 |
| ROCE(%) | 19.04 |
| Trade Value ( ₹ in Lacs) | 246.55 |
|---|---|
| Market Cap (₹ in Mn) | 0.03 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 132.71 |
| TTM EPS (₹) | 6.03 |
| P/E Ratio | 66.51 |
| Book Value(₹) | 14.25 |
| PAT Margin (%) | 13.67 |
| Face Value (₹) | 2.00 |
| ROCE(%) | 19.04 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 13841.0 | 3459.0 |
| Expenses | N/A | N/A |
| PBT | 4031.0 | 1205.0 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 3029.0 | 935.0 |
About Krishna Institute of Medical Sciences Ltd
| Founded | 1973 |
|---|---|
| Managing Director | Bhaskara Rao Bollineni |
| NSE Symbol | KIMS |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,29,145.05 | 1,784.30 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,72,988.62 | 6,734.20 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,49,322.13 | 4,490.20 | 3,140.10 - 3,140.10 |
| Apollo Hospitals Enterprise Ltd. | 1,20,125.61 | 8,467.65 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,12,149.13 | 1,389.40 | 1,165.70 - 1,165.70 |
| Zydus Lifesciences Ltd. | 1,09,422.92 | 1,109.00 | 835.50 - 835.50 |
| Dr. Reddy's Laboratories Ltd. | 1,06,482.91 | 1,276.00 | 1,148.40 - 1,148.40 |
| Lupin Ltd. | 1,02,996.20 | 2,263.25 | 1,836.80 - 1,836.80 |
| Max Healthcare Institute Ltd. | 97,913.19 | 1,005.30 | 903.00 - 903.00 |
| Mankind Pharma Ltd. | 97,382.57 | 2,388.55 | 1,909.70 - 1,909.70 |
No Records Found
Latest News
Krishna Institute of Medical Sciences informs about investor presentation
Krishna Institute of Medical Sciences informs about newspaper publication
Pursuant to the provisions of Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Krishna Institute of Medical Sciences has informed that it enclosed a copy of the newspaper publication on the audited (Standalone and Consolidated) financial results of the company for the quarter and financial year ended 31st March 2026, published in Financial Express (English) and Navatelangana (Telugu). The said publication may also be accessed on the website of the company.
The above information is a part of company’s filings submitted to BSE.
Krishna Institute of Medical Sciences informs about updates
Pursuant to the applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, Krishna Institute of Medical Sciences has informed that the company (‘KIMS’) has entered into a non-commercial brand association agreement with Dakshayani Healthcare Services (‘Renova’), a specialized oncology organization with proprietary clinical protocols and expertise in cancer research and academic supervision and has extensive experience in managing cancer centers across India. Under this arrangement, both KIMS and RENOVA will collaborate on a mutual, non-commercial basis, wherein RENOVA will be sharing its clinical expertise, knowledge, and best practices in Oncology care with KIMS. The association is intended to strengthen healthcare delivery standards, particularly in Oncology services, and enhance patient care outcomes.
The above information is a part of company’s filings submitted to BSE.
Krishna Institute of Medical Sciences informs about certificate
Ajanta Pharma informs about disclosure
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Krishna Institute of Medical Sciences Ltd is ₹796.20 as of 2026-06-09.
The market capitalisation of Krishna Institute of Medical Sciences Ltd is ₹32,035.12 as of 2026-06-08.
The 1-year return of Krishna Institute of Medical Sciences Ltd is -5.00% as of 2026-06-09.
The P/E ratio of Krishna Institute of Medical Sciences Ltd is 66.51 as of 2026-06-09.
The 52-week high and low of Krishna Institute of Medical Sciences Ltd are ₹811.00 and ₹575.80, respectively, as of 2026-06-09.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
